Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells

BackgroundChemotherapy resistance is the major cause of failure in neuroblastoma (NB) treatment. ATXN3 has been linked to various types of cancer and neurodegenerative diseases; however, its roles in NB have not been established. The aim of our study was to explore the role of ATXN3 in the cell deat...

Full description

Bibliographic Details
Main Authors: Baocheng Gong, Jinhua Zhang, Zhongyan Hua, Zhihui Liu, Carol J. Thiele, Zhijie Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
neuroblastoma
ataxin-3
BIM
Bcl-xl
perifosine
MK-2206
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.686898/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.686898/full

Similar Items